Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

815
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
815
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

417
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
417
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

632
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
632
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

3.0K
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The first known use of the double-orifice valve technique for Ebstein anomaly, performed 30 years ago.

The Journal of thoracic and cardiovascular surgery·2018
Same author

Role of paediatric assist device in bridge to transplant.

Annals of cardiothoracic surgery·2018
Same author

Repair for Congenital Mitral Valve Stenosis.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2018
Same author

Long-term outcome of simultaneous septal myectomy and anterior mitral leaflet retention plasty in hypertrophic obstructive cardiomyopathy: the Berlin experience.

Annals of cardiothoracic surgery·2017
Same author

Extra-anatomical bypass in complex and recurrent aortic coarctation and hypoplastic arch.

Interactive cardiovascular and thoracic surgery·2017
Same author

Repair of Parachute and Hammock Valve in Infants and Children: Early and Late Outcomes.

Seminars in thoracic and cardiovascular surgery·2017

Related Experiment Video

Updated: Feb 18, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.4K

Existing issues and valid concerns in continuous-flow ventricular assist devices.

Roland Hetzer1, Eva Maria Delmo Walter2

  • 1a Department of Cardiothoracic and Vascular Surgery , Cardio Centrum Berlin , Berlin , Germany.

Expert Review of Medical Devices
|November 23, 2017
PubMed
Summary

Continuous flow ventricular assist devices (VADs) are a vital treatment for advanced heart failure, offering improved patient outcomes and quality of life. Ongoing innovations aim to enhance VAD technology, though no single device has proven superior.

Keywords:
Ventricular assist devicesaortic valve insufficiencyheart failuremechanical circulatory supportpump thrombosis

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K

Related Experiment Videos

Last Updated: Feb 18, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Surgery
  • Heart Failure Management

Background:

  • Ventricular assist devices (VADs) are established surgical treatments for heart failure, surpassing heart transplantation frequency.
  • Complications and adverse events have driven the development of new VAD designs.
  • Continuous-flow VADs represent a significant advancement in supporting failing hearts.

Purpose of the Study:

  • To review the evolution of continuous-flow VADs in treating advanced heart failure.
  • To examine their role as a bridge to recovery, transplantation, or permanent therapy.
  • To discuss associated complications and long-term outcomes.

Main Methods:

  • Review of the evolution of continuous-flow VADs.
  • Analysis of their application in advanced heart failure.
  • Discussion of complications and long-term patient outcomes.

Main Results:

  • Continuous-flow VADs offer improved durability, smaller size, high energy efficiency, and lower thrombogenicity.
  • These devices lead to better survival rates, fewer adverse events, and enhanced quality of life.
  • Despite continuous innovation, no single continuous-flow VAD design has demonstrated superiority over others.

Conclusions:

  • Continuous-flow VADs are a crucial therapy for advanced heart failure with significant patient benefits.
  • Further research and development are ongoing to optimize VAD performance and patient outcomes.
  • The selection of a specific VAD may depend on individual patient factors and clinical goals.